Structured evidence table for Lemon Balm Sleep Support Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Lemon Balm Sleep Support Randomized Trial | Results PSQI scores significantly improved over time ( P P P P Discussion MOP, particularly at 400 mg/day, confirmed to significantly improve sleep and life quality, mood, and overall mental well-being. | 4 | Rondanelli M (2026) | Melissa phospholipids improves sleep quality and mental well-being: concluding results from clinical study in adults with emotional distress. |
| Lemon Balm Sleep Support Randomized Trial | Conclusion These findings support and extend the health benefits of MOP as a well-tolerated, safe natural approach in a dose-dependent frame to managing sleep quality and emotional distress. | 4 | Rondanelli M (2026) | Melissa phospholipids improves sleep quality and mental well-being: concluding results from clinical study in adults with emotional distress. |
| Lemon Balm Sleep Support Randomized Trial | (lemon balm) is a botanical support widely used for its calming and sleep-promoting properties. | 4 | Rondanelli M (2026) | Melissa phospholipids improves sleep quality and mental well-being: concluding results from clinical study in adults with emotional distress. |
| Lemon Balm Sleep Support Randomized Trial | Objective To evaluate the impact of daily supplementation with Melissa phospholipids (MOP) at 200 or 400 mg for 3 weeks on sleep quality and psychological well-being in adults with emotional distress and poor sleep quality. | 4 | Rondanelli M (2026) | Melissa phospholipids improves sleep quality and mental well-being: concluding results from clinical study in adults with emotional distress. |
| Lemon Balm Sleep Support Randomized Trial | A growing body of clinical evidence suggests that MO leaf extract supplementation possesses considerable neuropharmacological properties. | 4 | Kara M (2024) | An <i>in vitro</i> analysis of an innovative standardized phospholipid carrier-based <i>Melissa officinalis</i> L<i>.</i> extract as a potential neuromodulator for emotional distress and related conditions. |
| Lemon Balm Sleep Support Randomized Trial | Relissa™ demonstrated an improved neuroprotective antioxidant effect on SH-SY5Y cells against H 2 O 2 -induced oxidative stress. | 4 | Kara M (2024) | An <i>in vitro</i> analysis of an innovative standardized phospholipid carrier-based <i>Melissa officinalis</i> L<i>.</i> extract as a potential neuromodulator for emotional distress and related conditions. |
| Lemon Balm Sleep Support Randomized Trial | Moreover, cell-free chemical tests, including TEAC-ABTS, DPPH radical scavenging, FRAP, ORAC, and HORAC assays, validated the improved antioxidant effect of Relissa™ vs. | 4 | Kara M (2024) | An <i>in vitro</i> analysis of an innovative standardized phospholipid carrier-based <i>Melissa officinalis</i> L<i>.</i> extract as a potential neuromodulator for emotional distress and related conditions. |
| Lemon Balm Sleep Support Randomized Trial | (MO), commonly known as lemon balm, a member of the mint family, is considered a calming herb. | 4 | Kara M (2024) | An <i>in vitro</i> analysis of an innovative standardized phospholipid carrier-based <i>Melissa officinalis</i> L<i>.</i> extract as a potential neuromodulator for emotional distress and related conditions. |
Source documents